While organ transplantation can significantly improve the quality of life of critically ill patients, it comes with substantial risks that transplant recipients should be aware of. Following transplantation, the recipient’s need for immunosuppression medications can lead to an increased risk of infections and certain cancers. For transplant recipients, the risk of skin cancer can be up to 100-fold higher. Pre-transplant screening and patient education are essential components of the evaluation process for potential recipients and require a team approach by dermatology and the transplant care providers.

Preventive Treatment of Skin Cancer
The management of skin cancer in transplant patients follows the same principles as with all patients susceptible to skin cancer, but with a heightened sense of importance. Outdoor activities should be scheduled earlier or later in the day rather than during the peak sun hours of 10am to 4pm. Broad spectrum sunscreen with a sun protection factor of 30 or greater should be applied to all exposed skin surfaces as part of the daily morning routine and reapplied when in the sun. Transplant patients should also be advised not to seek a tan via natural or artificial ultraviolet exposure. Sun Protective Gear such as hats, clothing, and sunglasses are important and highly encouraged.

Given that skin cancer can’t always be prevented in transplant recipients, patients should undergo regular screening. It’s highly recommended that transplant teams coordinate closely with dermatologists to ensure optimal patient care. Skin screenings are encouraged on a 6-month basis for patients with extensive sun damage or a history of skin cancer.
In addition to practicing daily sun protection, transplant recipients should examine their own skin regularly and consult a dermatologist immediately if anything suspicious is found.




